Virginia Cabello
YOU?
Author Swipe
View article: Identification of early predictors of clinical remission in primary membranous nephropathy: a <i>post hoc</i> analysis of the STARMEN trial
Identification of early predictors of clinical remission in primary membranous nephropathy: a <i>post hoc</i> analysis of the STARMEN trial Open
Background Patients with primary membranous nephropathy may progress to advanced chronic kidney disease despite immunosuppressive therapy (IST). Prediction of treatment response based on early and combined assessment of several standard cl…
View article: Prognostic and therapeutic monitoring value of plasma and urinary cytokine profile in primary membranous nephropathy: the STARMEN trial cohort
Prognostic and therapeutic monitoring value of plasma and urinary cytokine profile in primary membranous nephropathy: the STARMEN trial cohort Open
Background Primary membranous nephropathy (PMN) is usually caused by anti-phospholipase A2 receptor (PLA2R) autoantibodies. There are different therapeutic options according to baseline risk. Novel biomarkers are needed to optimize risk st…
View article: On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome
On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome Open
View article: Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy
Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy Open
Key Points Kidney survival in C3 glomerulopathy is significantly higher in patients with a disease chronicity score <4 and proteinuria <3.5 g/d, regardless of baseline eGFR. A faster eGFR decline in C3 glomerulopathy is associated with hig…
View article: Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy
Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy Open
Background C3 glomerulopathy is a rare and heterogeneous complement-driven disease. It is often challenging to accurately predict in clinical practice the individual kidney prognosis at baseline. We herein sought to develop and validate a …
View article: IgA Nephropathy Is the Most Common Underlying Disease in Patients With Anticoagulant-Related Nephropathy
IgA Nephropathy Is the Most Common Underlying Disease in Patients With Anticoagulant-Related Nephropathy Open
View article: The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy Open
View article: Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the Disease
Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the Disease Open
Background and objectives C3 glomerulopathy is a complement-mediated disease arising from abnormalities in complement genes and/or antibodies against complement components. Previous studies showed that treatment with corticosteroids plus m…
View article: Complement Activation and Thrombotic Microangiopathies
Complement Activation and Thrombotic Microangiopathies Open
Background and objectives Atypical hemolytic uremic syndrome is a form of thrombotic microangiopathy caused by dysregulation of the alternative complement pathway. There is evidence showing complement activation in other thrombotic microan…
View article: Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome
Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome Open
View article: Prevalence and clinical characteristics of renal transplant patients with true resistant hypertension
Prevalence and clinical characteristics of renal transplant patients with true resistant hypertension Open
The present study provides evidence about the prevalence of true resistant hypertension in renal-transplant patients. It also shows the very high cardiovascular risk of true resistant hypertension and the elevated association of this condi…